Literature DB >> 8741939

The relative salience of morphine and contextual cues as conditioned stimuli.

N M Bormann1, D A Overton.   

Abstract

Two experiments were conducted to delineate further the properties of conditioning when morphine is used as a conditioned stimulus (CS) in the conditioned suppression of drinking paradigm. Experiment 1 used a test for overshadowing designed to compare the relative salience of contextual cues (metal box) and morphine induced cues (6 mg/kg, IP) as CSs when each was paired with a foot shock unconditioned stimulus (US) in water deprived rats. Six groups (six rats each) were exposed to conditioning procedures during which the conditioning context was present 19 h (groups 1 and 2), 90 min (groups 3 and 4), or 5 min (groups 5 and 6) before shock onset, and morphine (in groups 1, 3, and 5) or saline (in groups 2, 4, and 6) was injected 10 min before shock. Subsequently, the magnitude of suppression of drinking in response to morphine, to the metal box, and to morphine plus the metal box was measured. Only group 1 (19 h group) suppressed drinking in response to morphine, while groups 3-6 suppressed drinking whenever tested in the metal box. The results indicate that morphine cues acted as a CS that elicited suppression of drinking in group 1, and that contextual cues present up to 90 min before morphine cues overshadowed morphine. Experiment 2 showed that expression of the conditioned response to morphine was blocked by naloxone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741939     DOI: 10.1007/bf02246173

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Drug interactions measured through taste aversion procedures with an emphasis on medical implications.

Authors:  S Revusky
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

2.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

3.  Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

Authors:  D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Dose effects on heart rate conditioning when pentobarbital is the CS and amphetamine is the US.

Authors:  S Revusky; S Reilly
Journal:  Pharmacol Biochem Behav       Date:  1990-08       Impact factor: 3.533

5.  Rotational behavior as a classically conditioned response to pentobarbital administration.

Authors:  P B Silverman; J Grabowski; K E Lane
Journal:  Eur J Pharmacol       Date:  1992-03-03       Impact factor: 4.432

6.  Centrally acting drugs act as conditioned stimuli in a conditioned suppression of drinking task.

Authors:  D A Overton; C F Shen; T A Tatham
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Morphine as a conditioned stimulus in a conditioned emotional response paradigm.

Authors:  N M Bormann; D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Conditioned suppression of an operant response using d-amphetamine as the conditioned stimulus.

Authors:  E G Turner; H L Altshuler
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

9.  Pavlovian conditioning between co-administered drugs: elicitation of an apomorphine-induced antiparkinsonian response by scopolamine.

Authors:  R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Pairings of a drug or place conditioned stimulus with lithium chloride produce conditioned sickness, not antisickness.

Authors:  B T Lett
Journal:  Behav Neurosci       Date:  1992-02       Impact factor: 1.912

View more
  1 in total

1.  The interoceptive Pavlovian stimulus effects of caffeine.

Authors:  Jennifer E Murray; Chia Li; Matthew I Palmatier; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.